Exploring Immune Redox Modulation in Bacterial Infections: Insights into Thioredoxin-Mediated Interactions and Implications for Understanding Host–Pathogen Dynamics
Antioxidants · 29.04.2024 · 13 (5) · 545
DOI: 10.3390/antiox13050545 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 29.04.2024. Verfasst von Omer M A Dagah und 12 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Research Center of Coptis Development and Utilization/Key Laboratory of Luminescence Analysis and Molecular Sensing, Ministry of Educatio…. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Project of Innovation Research 2035 Pilot Plan of Southwest University, Natural Science Foundation of Chongqing, Hundred Talents Plan of Chongqing and Southwest University ‘Gathering Talent Project’.
Abstract (Originalsprache)
Bacterial infections trigger a multifaceted interplay between inflammatory mediators and redox regulation. Recently, accumulating evidence has shown that redox signaling plays a significant role in immune initiation and subsequent immune cell functions. This review addresses the crucial role of the thioredoxin (Trx) system in the initiation of immune reactions and regulation of inflammatory responses during bacterial infections. Downstream signaling pathways in various immune cells involve thiol-dependent redox regulation, highlighting the pivotal roles of thiol redox systems in defense mechanisms. Conversely, the survival and virulence of pathogenic bacteria are enhanced by their ability to counteract oxidative stress and immune attacks. This is achieved through the reduction of oxidized proteins and the modulation of redox-sensitive signaling pathways, which are functions of the Trx system, thereby fortifying bacterial resistance. Moreover, some selenium/sulfur-containing compounds could potentially be developed into targeted therapeutic interventions for pathogenic bacteria. Taken together, the Trx system is a key player in redox regulation during bacterial infection, and contributes to host–pathogen interactions, offering valuable insights for future research and therapeutic development.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Engineering Research Center of Coptis Development and Utilization/Key Laboratory of Luminescence Analysis and Molecular Sensing, Ministry of Education, College of Pharmaceutical Sciences, Southwest University, Chongqing…
- Hygeia Hospital, Chongqing 401331, China.
ORCID-Profile: Omer M A Dagah, Jun Lu
Förderung
- Key Project of Innovation Research 2035 Pilot Plan of Southwest University
- Natural Science Foundation of Chongqing
- Hundred Talents Plan of Chongqing and Southwest University ‘Gathering Talent Project’
Zitieren
APA
Dagah, O. M. A., Silaa, B. B., Zhu, M., Pan, Q., Qi, L., Liu, X., Liu, Y., Peng, W., Ullah, Z., Yudas, A. F., Muhammad, A., Zhang, X., & Lu, J. (2024). Exploring Immune Redox Modulation in Bacterial Infections: Insights into Thioredoxin-Mediated Interactions and Implications for Understanding Host–Pathogen Dynamics. Antioxidants, 13(5), 545. https://doi.org/10.3390/antiox13050545
Vancouver
Dagah OMA, Silaa BB, Zhu M, Pan Q, Qi L, Liu X, et al. Exploring Immune Redox Modulation in Bacterial Infections: Insights into Thioredoxin-Mediated Interactions and Implications for Understanding Host–Pathogen Dynamics. Antioxidants. 2024;13(5):545. doi:10.3390/antiox13050545
BibTeX
@article{Dagah2024,
author = {Dagah, Omer M A and Silaa, Billton Bryson and Zhu, Minghui and Pan, Qiu and Qi, Linlin and Liu, Xinyu and Liu, Yuqi and Peng, Wenjing and Ullah, Zakir and Yudas, Appolonia F and Muhammad, Amir and Zhang, Xianquan and Lu, Jun},
title = {Exploring Immune Redox Modulation in Bacterial Infections: Insights into Thioredoxin-Mediated Interactions and Implications for Understanding Host–Pathogen Dynamics},
journal = {Antioxidants},
year = {2024},
volume = {13},
number = {5},
pages = {545},
doi = {10.3390/antiox13050545}
}
EUVIMED